Advanced Diabetes Treatment Centers
11
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
100.0%
11 terminated/withdrawn out of 11 trials
0.0%
-86.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus
Role: collaborator
Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus
Role: collaborator
Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1
Role: collaborator
Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes
Role: collaborator
Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness
Role: collaborator
Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus
Role: collaborator
Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes
Role: collaborator
Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes
Role: collaborator
Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics
Role: collaborator
Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes
Role: collaborator
Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes
Role: collaborator
All 11 trials loaded